STRIDES PHARMA SCIENCE LTD.

NSE : STARBSE : 532531ISIN CODE : INE939A01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE836.008.95 (+1.08 %)
PREV CLOSE ( ) 827.05
OPEN PRICE ( ) 827.20
BID PRICE (QTY) 835.30 (2)
OFFER PRICE (QTY) 837.10 (2)
VOLUME 1155
TODAY'S LOW / HIGH ( )827.05 836.50
52 WK LOW / HIGH ( )306.05 860
NSE836.905.9 (+0.71 %)
PREV CLOSE( ) 831.00
OPEN PRICE ( ) 828.95
BID PRICE (QTY) 836.25 (9)
OFFER PRICE (QTY) 836.95 (1)
VOLUME 19511
TODAY'S LOW / HIGH( ) 822.10 837.00
52 WK LOW / HIGH ( )306 865
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.